anesthesia. Dissociative anaesthesia and sensory loss
Conditions
Interventions
Intervention 1: In the first interventional group 46 patients receive intravenous propofol in a dose of one mg per kg of weight(Ampoules made in Iran by drug Behestan Co.) for anesthesia induction.
Treatment - Drugs
In the first interventional group 46 patients receive intravenous propofol in a dose of one mg per kg of weight(Ampoules made in Iran by drug Behestan Co.) for anesthesia induction. Dose of 3 mg pe
In the second interventional group, 46 patients receive intravenous propofol in a dose of 2.5 mg per kg of weight(Ampoules made in Iran by drug Behestan Co.) for anesthesia induction. Dose of 3 mg
Sponsors
Vice chancellor for research, Shahrekord University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 80 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Aged between 20 and 80 years old, patients under surgery with general Anesthesia, patients with class I and ASA class II. Exclusion criteria: any observable unpredictable complications after injection of propofol; patients with ASA class higher than I and II, patients with drug sensitivity, and patients with contraindications due to the use of this drug.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Movement Score. Timepoint: 1 min after the induction of anesthesia. Method of measurement: observation.;Blood pressure. Timepoint: 5 min before induction of anesthesia,1 min and 5min after induction of anesthesia and after intubation. Method of measurement: monitoring devices.;Level of consciousness. Timepoint: 5 minutes before induction of anesthesia, 1 minute and 5 minutes after intervention and after intubation. Method of measurement: BIS monitoring set. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Gholamreza Shabanian
Shahrekord University of Medical Sciences
Outcome results
None listed